Bristol Myers Squibb (BMY) Operating Income Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Op. Inc Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
80.35% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
2.93% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
6.88% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-411.15% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
126.32% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
15.60% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-0.98% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-193.55% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-193.55% |
| Dec 31, 2025 |
43.35% |
| Sep 30, 2025 |
74.94% |
| Jun 30, 2025 |
19.28% |
| Mar 31, 2025 |
99.57% |
| Dec 31, 2024 |
-332.96% |
| Sep 30, 2024 |
-247.15% |
| Jun 30, 2024 |
-94.79% |
| Mar 31, 2024 |
-7,182.35% |
| Dec 31, 2023 |
-45.91% |
| Sep 30, 2023 |
-156.25% |
| Jun 30, 2023 |
-33.46% |
| Mar 31, 2023 |
126.02% |
| Dec 31, 2022 |
-47.39% |
| Sep 30, 2022 |
-7.46% |
| Jun 30, 2022 |
15.24% |
| Mar 31, 2022 |
-152.09% |
| Dec 31, 2021 |
96.27% |
| Sep 30, 2021 |
45.31% |
| Jun 30, 2021 |
16.14% |
| Mar 31, 2021 |
92.16% |
| Dec 31, 2020 |
-409.77% |
| Sep 30, 2020 |
44.44% |
| Jun 30, 2020 |
-446.94% |
| Mar 31, 2020 |
-2,658.71% |
| Dec 31, 2019 |
-2,396.19% |
| Sep 30, 2019 |
-184.97% |
| Jun 30, 2019 |
82.31% |
| Mar 31, 2019 |
-20.51% |
| Dec 31, 2018 |
88.37% |
| Sep 30, 2018 |
231.06% |
| Jun 30, 2018 |
-304.38% |
| Mar 31, 2018 |
-71.74% |
| Dec 31, 2017 |
-182.19% |
| Sep 30, 2017 |
-255.91% |
| Jun 30, 2017 |
-166.99% |
| Mar 31, 2017 |
14.43% |
| Dec 31, 2016 |
76.51% |
| Sep 30, 2016 |
330.91% |
| Jun 30, 2016 |
142.56% |
| Mar 31, 2016 |
0.33% |
| Dec 31, 2015 |
-32.75% |
| Sep 30, 2015 |
-11,100.00% |
| Jun 30, 2015 |
-76.98% |
| Mar 31, 2015 |
3,435.29% |
| Dec 31, 2014 |
-153.96% |
| Sep 30, 2014 |
100.28% |
| Jun 30, 2014 |
6.06% |
| Mar 31, 2014 |
104.37% |
| Dec 31, 2013 |
28.11% |
| Sep 30, 2013 |
84.11% |
| Jun 30, 2013 |
-210.75% |
| Mar 31, 2013 |
-153.73% |
| Dec 31, 2012 |
-347.58% |
| Sep 30, 2012 |
-630.97% |
| Jun 30, 2012 |
-160.19% |
| Mar 31, 2012 |
70.75% |
| Dec 31, 2011 |
22,800.00% |
| Sep 30, 2011 |
26.65% |
| Jun 30, 2011 |
-1.90% |
| Mar 31, 2011 |
190.41% |
| Dec 31, 2010 |
99.12% |
| Sep 30, 2010 |
34.68% |
| Jun 30, 2010 |
6.06% |
| Mar 31, 2010 |
386.67% |
